NDRA insider transaction filings
ENDRA Life Sciences Inc. — 11 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-03-04. Screen NDRA transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-04 | 4 | Jacroux Richard — Chief Financial Officer | Grant/award (A): 13,461 @ $0 | EDGAR |
| 2026-03-04 | 4 | Tokman Alexander Y — Chief Executive Officer, Director | Grant/award (A): 26,921 @ $0 | EDGAR |
| 2026-01-23 | 4 | Harsh Michael — Director | Grant/award (A): 60,324 @ $0 | EDGAR |
| 2026-01-23 | 4 | Jacroux Richard — Chief Financial Officer | Grant/award (A): 20,000 @ $0 | EDGAR |
| 2026-01-23 | 4 | Basenese Lou — Director | Grant/award (A): 60,324 @ $0 | EDGAR |
| 2026-01-23 | 4 | Tokman Alexander Y — Chief Executive Officer, Director | Grant/award (A): 75,000 @ $0 | EDGAR |
| 2026-01-23 | 4 | DIGIANDOMENICO ANTHONY — Director | Grant/award (A): 60,324 @ $0 | EDGAR |
| 2025-10-15 | 4 | DIGIANDOMENICO ANTHONY — Director | Grant/award (A): 70,822 @ $7.06 · Grant/award (A): 141,644 (derivative) @ $7.06 | EDGAR |
| 2025-07-01 | 4 | Basenese Lou — Director | Grant/award (A): 5,384 @ $0 | EDGAR |
| 2025-07-01 | 4 | Harsh Michael — Director | Grant/award (A): 5,384 @ $0 | EDGAR |
| 2025-07-01 | 4 | DIGIANDOMENICO ANTHONY — Director | Grant/award (A): 5,384 @ $0 | EDGAR |
Recent 8-K events — ENDRA Life Sciences Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-17 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-09 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.01 — Changes in Control of Registrant 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-25 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-21 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-03-31 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-25 | 8-K | ? 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-15 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-28 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=NDRA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →